@article{e44556e878c041cd96c8ed66226faef9,
title = "Phase II study on weekly bolus topotecan in advanced or recurrent cervical cancer",
abstract = "It was the aim of our study to evaluate the efficacy and safety of weekly topotecan in patients with advanced or recurrent cervical disease.",
keywords = "Adenocarcinoma, Adult, Aged, Antineoplastic Agents, Carcinoma, Squamous Cell, Drug Administration Schedule, Female, Humans, Infusions, Intravenous, Injections, Intravenous, Middle Aged, Neoplasm Recurrence, Local, Neoplasm Staging, Topoisomerase I Inhibitors, Topotecan, Treatment Failure, Uterine Cervical Neoplasms, Adenocarcinoma, Adult, Aged, Antineoplastic Agents, Carcinoma, Squamous Cell, Drug Administration Schedule, Female, Humans, Infusions, Intravenous, Injections, Intravenous, Middle Aged, Neoplasm Recurrence, Local, Neoplasm Staging, Topoisomerase I Inhibitors, Topotecan, Treatment Failure, Uterine Cervical Neoplasms",
author = "Domenica Lorusso and Sara Mainenti and Antonella Pietragalla and E Fusco and Paola Malaguti and Valeria Masciullo and Giovanni Scambia",
year = "2011",
doi = "10.1159/000330537",
language = "English",
volume = "80",
pages = "390--394",
journal = "Oncology",
issn = "0030-2414",
publisher = "S. Karger AG",
}
